Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in… Click to show full abstract
Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in 1-3% of patients, for which there is a need for increased awareness
               
Click one of the above tabs to view related content.